Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension

Pulmonary hypertension (PH) has been linked to worse outcomes in chronic lung diseases. The presence of PH in the setting of underlying Interstitial Lung Disease (ILD) is strongly associated with decreased exercise and functional capacity, an increased risk of hospitalizations and death. Examining t...

ver descrição completa

Detalhes bibliográficos
Autores: Nikkho, Sylvia M., Richter, Manuel J., Shen, Eric, Abman, Steven H., Antoniou, Katerina, Chung, Jonathan, Fernandes, Peter, Hassoun, Paul, Lazarus, Howard M., Olschewski, Horst, Piccari, Lucilla, Psotka, Mitchell, Saggar, Rajan, Shlobin, Oksana A., Stockbridge, Norman, Vitulo, Patrizio, Vizza, Carmine Dario, Wort, Stephen John, Nathan, Steven D.
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Recursos:Universitat Pompeu Fabra
Repositorio:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/55725
Acesso em linha:http://hdl.handle.net/10230/55725
http://dx.doi.org/10.1002/pul2.12127
Access Level:acceso abierto
Palavra-chave:Epidemiology
Interstitial lung disease
Prognosis
Pulmonary hypertension
Symptom assessment and management
id ES_988cfefabdfce7be0bb6b1f2fedac911
oai_identifier_str oai:repositori.upf.edu:10230/55725
network_acronym_str ES
network_name_str España
repository_id_str
spelling Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertensionNikkho, Sylvia M.Richter, Manuel J.Shen, EricAbman, Steven H.Antoniou, KaterinaChung, JonathanFernandes, PeterHassoun, PaulLazarus, Howard M.Olschewski, HorstPiccari, LucillaPsotka, MitchellSaggar, RajanShlobin, Oksana A.Stockbridge, NormanVitulo, PatrizioVizza, Carmine DarioWort, Stephen JohnNathan, Steven D.EpidemiologyInterstitial lung diseasePrognosisPulmonary hypertensionSymptom assessment and managementPulmonary hypertension (PH) has been linked to worse outcomes in chronic lung diseases. The presence of PH in the setting of underlying Interstitial Lung Disease (ILD) is strongly associated with decreased exercise and functional capacity, an increased risk of hospitalizations and death. Examining the scope of this issue and its impact on patients is the first step in trying to define a roadmap to facilitate and encourage future research in this area. The aim of our working group is to strengthen the communities understanding of PH due to lung diseases and to improve the care and quality of life of affected patients. This introductory statement provides a broad overview and lays the foundation for further in-depth papers on specific topics pertaining to PH-ILD.Wiley202320232022info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/55725http://dx.doi.org/10.1002/pul2.12127reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésPulm Circ. 2022 Jul 1;12(3):e12127© 2022 The Authors. Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.http://creativecommons.org/licenses/by-nc/4.0/info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/557252026-06-12T07:21:37Z
dc.title.none.fl_str_mv Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension
title Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension
spellingShingle Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension
Nikkho, Sylvia M.
Epidemiology
Interstitial lung disease
Prognosis
Pulmonary hypertension
Symptom assessment and management
title_short Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension
title_full Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension
title_fullStr Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension
title_full_unstemmed Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension
title_sort Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension
dc.creator.none.fl_str_mv Nikkho, Sylvia M.
Richter, Manuel J.
Shen, Eric
Abman, Steven H.
Antoniou, Katerina
Chung, Jonathan
Fernandes, Peter
Hassoun, Paul
Lazarus, Howard M.
Olschewski, Horst
Piccari, Lucilla
Psotka, Mitchell
Saggar, Rajan
Shlobin, Oksana A.
Stockbridge, Norman
Vitulo, Patrizio
Vizza, Carmine Dario
Wort, Stephen John
Nathan, Steven D.
author Nikkho, Sylvia M.
author_facet Nikkho, Sylvia M.
Richter, Manuel J.
Shen, Eric
Abman, Steven H.
Antoniou, Katerina
Chung, Jonathan
Fernandes, Peter
Hassoun, Paul
Lazarus, Howard M.
Olschewski, Horst
Piccari, Lucilla
Psotka, Mitchell
Saggar, Rajan
Shlobin, Oksana A.
Stockbridge, Norman
Vitulo, Patrizio
Vizza, Carmine Dario
Wort, Stephen John
Nathan, Steven D.
author_role author
author2 Richter, Manuel J.
Shen, Eric
Abman, Steven H.
Antoniou, Katerina
Chung, Jonathan
Fernandes, Peter
Hassoun, Paul
Lazarus, Howard M.
Olschewski, Horst
Piccari, Lucilla
Psotka, Mitchell
Saggar, Rajan
Shlobin, Oksana A.
Stockbridge, Norman
Vitulo, Patrizio
Vizza, Carmine Dario
Wort, Stephen John
Nathan, Steven D.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Epidemiology
Interstitial lung disease
Prognosis
Pulmonary hypertension
Symptom assessment and management
topic Epidemiology
Interstitial lung disease
Prognosis
Pulmonary hypertension
Symptom assessment and management
description Pulmonary hypertension (PH) has been linked to worse outcomes in chronic lung diseases. The presence of PH in the setting of underlying Interstitial Lung Disease (ILD) is strongly associated with decreased exercise and functional capacity, an increased risk of hospitalizations and death. Examining the scope of this issue and its impact on patients is the first step in trying to define a roadmap to facilitate and encourage future research in this area. The aim of our working group is to strengthen the communities understanding of PH due to lung diseases and to improve the care and quality of life of affected patients. This introductory statement provides a broad overview and lays the foundation for further in-depth papers on specific topics pertaining to PH-ILD.
publishDate 2022
dc.date.none.fl_str_mv 2022
2023
2023
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/55725
http://dx.doi.org/10.1002/pul2.12127
url http://hdl.handle.net/10230/55725
http://dx.doi.org/10.1002/pul2.12127
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Pulm Circ. 2022 Jul 1;12(3):e12127
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by-nc/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repositorio Digital de la UPF
instname:Universitat Pompeu Fabra
instname_str Universitat Pompeu Fabra
reponame_str Repositorio Digital de la UPF
collection Repositorio Digital de la UPF
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869414202274217984
score 15,812455

Registos relacionados